This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
US Biological
product type :
antibody
product name :
Epidermal Growth Factor Receptor, phosphorylated (Tyr1045) (erbB, EGFR)
catalog :
E3375-53
quantity :
100 ul
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
reactivity :
human
product information
Catalog Number :
E3375-53
Product wo Prefix :
Epidermal Growth Factor Receptor, phosphorylated (Tyr1045) (erbB, EGFR)
Host :
rabbit
Product Type :
Pab
Antigen Modification :
Phosphorylated
Category :
Antibodies
Size1 :
100 ul
Isotype :
IgG
Desc1 :
Epidermal growth factor (EGF) receptor is a 170kD single-pass transmembrane tyrosine kinase. Ligand binding to this receptor results in receptor dimerization, autophosphorylation (in trans), activation of various downstream signaling molecules and lysosomal degradation (1,2). Tyrosine 845 resides in the activation loop of the receptor kinase domain (3,4). Phosphorylation of Tyr845 may stabilize the activation loop, maintain the enzyme in an active state and provide a binding surface for substrate proteins. It has been shown that c-Src is involved in phosphorylation of the EGF receptor on Tyr845, which is associated with modulation of receptor function (5). Phospho-tyrosine 992 of activated EGF receptor is a direct binding site for the phospholipase C-gamma (PLC-gamma) SH2 domain (6). This binding results in activation of PLC-gamma-mediated downstream signaling. Phosphorylation of Tyr1045 creates a major docking site for c-Cbl (7). Binding of c-Cbl to the activated EGF receptor leads to assembly of ubiquitination machinery to the receptor, and enables receptor ubiquitination and degradation (8). Phospho-tyrosine 1068 of activated EGF receptor is a direct binding site for the Grb2/SH2 domain (9). This binding results in Ras activation through a Grb2/Sos-1 signaling mechanism (2). Applications: Suitable for use in Immunofluorescence, ELISA, Western Blot, and Immunohistochemistry . Other applications not tested. Recommended Dilution: Western Blot: 1:1000 Immunohistochemistry (Paraffin): 1:200 Immunofluorescence (IF-IC): 1:25 Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. For long-term storage, store at -20°C. Aliquots are stable for at least 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Calc Crossreactivity :
Hu Rt
Immunogen :
Synthetic phosphopeptide corresponding to residues surrounding Tyr1045 of human EGF receptor.
Specificity :
Recognizes human EGF receptor only when phosphorylated at Tyr1045. May crossreact with other activated EGF receptor family members such as ErB2. Species crossreactivity: rat.
Purity :
Purified by Protein A affinity chromatography.
Form :
Supplied as a liquid in 10mM HEPES, pH 7.5, 150mM sodium chloride, 0.1mg/ml BSA, 50% glycerol. No preservative added.
Concentration :
Not Determined
Desc2 :
Product Type: Pab Isotype: IgG Host: rabbit Source: human Concentration: Not Determined. Form: Supplied as a liquid in 10mM HEPES, pH 7.5, 150mM sodium chloride, 0.1mg/ml BSA, 50% glycerol. No preservative added. Purity: Purified by Protein A affinity chromatography. Immunogen: Synthetic phosphopeptide corresponding to residues surrounding Tyr1045 of human EGF receptor. Specificity: Recognizes human EGF receptor only when phosphorylated at Tyr1045. May crossreact with other activated EGF receptor family members such as ErB2. Species crossreactivity: rat. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Calc Applications Abbrev :
E IC IF IHC WB
Storage Temperature :
-20°C
Reference :
1. Hackel, P.O. et al. (1999) Curr. Opin. Cell Biol. 11: 184–189. 2. Zwick , E. et al. (1999) Trends Pharmacol. Sci. 20, 408–412. 3. Cooper, J.A. and Howell, B. (1993) Cell 73: 1051–1054. 4. Hubbard, S.R. et al. (1994) Nature 372: 746–754. 5. Biscardi, J.S. et al. (1999) J. Biol. Chem. 274: 8335–8343. 6. Emlet, D.R. et al. (1997) J. Biol. Chem. 272: 4079–4086. 7. Levkowitz, G. et al. (1999) Mol. Cell 4: 1029–1040. 8. Ettenberg, S.A. et al. (1999) Oncogene 18:1855–1866. 9. Rojas, M. et al. (1996) J. Biol. Chem. 271: 27456–27461. 10. Iordanov, M.S. et al. (2002) Mol. Cell. Biol. 22: 5380–5394.
Picture 1 File Name :
https://usbio-images.r.worldssl.net/prodimages/8/E3375-53_1.jpg
company information
US Biological
4 Technology Way
Salem, MA01970
service@usbio.net
https://www.usbio.net
800-520-3011
headquarters: USA
United States Biological is a primary brand for the Life Science Industry. We are committed to reducing the cost of research with value, integrity and a truly personal buying experience.